The Memphis Business Group on Health (MBGH) is pleased to make this forum, including all web pages and web sites accessed from this page, available to Web Site users and others. However, the MBGH does not render legal or consultation services, and legal counsel must be consulted to determine any material’s applicability to any specific situation. MBGH cannot warrant or control the quality, accuracy, or validity of the information posted here. Comments posted on this blog are the sole responsibility of their writers. Use of such information is at the risk of the accessing user and the accessing user assumes all liabilities that may result from such use.




CVS Urges Cost Controls For New Cholesterol Medications

Citing the concern that eventually 15 million patients at an annual cost of $150 billion of a new class of cholesterol medications, CVS Health warned that the cost of these new medications could overwhelm the U.S. health care system "if rigid cost control mechanisms are not put in place".

According to Reuters, CVS negotiates drug pricing for 65 million through contracts with employers and health plans.

The concerns around cholesterol medications are closely following criticism regarding the new Hepatitis C drugs, which may cost up to approximately $94,500 for a course of treatment. But unlike Hep C drugs which are effective with one course of treatment, the new cholesterol medications are essentially taken for life and significant annual financial implications for patients undergoing treatment and employers and plans covering the cost of that treatment.

Express Scripts also voiced concerns although their cost estimates are somewhat lower than CVS estimates.

Learn more about specialty pharmaceutical management on a February 26 webinar and in-person at a 1/2 day workshop in Franklin, TN on April 1. Email Cristie at [email protected] for more information and registration details.

Read the Reuters article.

Posted by Cristie Travis at 3:40 PM

From Our Blog

Say Hello

Please feel free to drop us a line via the button below. We try to respond to every email we receive.

Stay Connected

Join the MBGH community and keep up to date with issues concerning Memphis healthcare.

Facebook Twitter LinkedIn Feed